-
1
-
-
0345402838
-
Diagnostic and Statistical Manual of Mental Disorders
-
Washington, DC, USA: American Psychiatric Association
-
American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 4th ed. 1994;American Psychiatric Association, Washington, DC, USA
-
(1994)
4th Ed.
-
-
Psychiatric Association, A.1
-
2
-
-
0030795988
-
Multiple fixed doses of "seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group
-
Arvanitis L.A., Miller B.G. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group. Biol. Psychiatry. 42(4):1997;233-246
-
(1997)
Biol. Psychiatry
, vol.42
, Issue.4
, pp. 233-246
-
-
Arvanitis, L.A.1
Miller, B.G.2
-
3
-
-
0024358369
-
A rating scale for drug-induced akathisia
-
Barnes T.R. A rating scale for drug-induced akathisia. Br. J. Psychiatry. 154:1989;672-676
-
(1989)
Br. J. Psychiatry
, vol.154
, pp. 672-676
-
-
Barnes, T.R.1
-
4
-
-
0001127258
-
An analysis of time relations of the electrocardiogram
-
Bazett H.C. An analysis of time relations of the electrocardiogram. Heart. 7:1920;353-370
-
(1920)
Heart
, vol.7
, pp. 353-370
-
-
Bazett, H.C.1
-
5
-
-
0031978034
-
Risperidone versus clozapine in treatment-resistant chronic schizophrenia: A randomized double-blind study. The Risperidone Study Group
-
Bondolfi G., Dufour H., Patris M., May J.P., Billeter U., Eap C.B., Baumann P. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group. Am. J. Psychiatry. 155(4):1998;499-504
-
(1998)
Am. J. Psychiatry
, vol.155
, Issue.4
, pp. 499-504
-
-
Bondolfi, G.1
Dufour, H.2
Patris, M.3
May, J.P.4
Billeter, U.5
Eap, C.B.6
Baumann, P.7
-
7
-
-
0033558072
-
Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia
-
Breier A., Hamilton S.H. Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia. Biol. Psychiatry. 45(4):1999;403-411
-
(1999)
Biol. Psychiatry
, vol.45
, Issue.4
, pp. 403-411
-
-
Breier, A.1
Hamilton, S.H.2
-
8
-
-
0033047901
-
Clozapine and risperidone in chronic schizophrenia: Effects on symptoms, parkinsonian side effects, and neuroendocrine response
-
Breier A.F., Malhotra A.K., Su T.P., Pinals D.A., Elman I., Adler C.M., Lafargue R.T., Clifton A., Pickar D. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response. Am. J. Psychiatry. 156(2):1999;294-298
-
(1999)
Am. J. Psychiatry
, vol.156
, Issue.2
, pp. 294-298
-
-
Breier, A.F.1
Malhotra, A.K.2
Su, T.P.3
Pinals, D.A.4
Elman, I.5
Adler, C.M.6
Lafargue, R.T.7
Clifton, A.8
Pickar, D.9
-
9
-
-
0035972733
-
Successful outcome using quetiapine in a case of treatment-resistant schizophrenia with assaultive behavior
-
Brooks J.O. III Successful outcome using quetiapine in a case of treatment-resistant schizophrenia with assaultive behavior. Schizophr. Res. 50(1-2):2001;133-134
-
(2001)
Schizophr. Res.
, vol.50
, Issue.12
, pp. 133-134
-
-
Brooks III, J.O.1
-
10
-
-
0031746826
-
Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome
-
Buchanan R.W., Breier A., Kirkpatrick B., Ball P., Carpenter W.T. Jr. Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome. Am. J. Psychiatry. 155(6):1998;751-760
-
(1998)
Am. J. Psychiatry
, vol.155
, Issue.6
, pp. 751-760
-
-
Buchanan, R.W.1
Breier, A.2
Kirkpatrick, B.3
Ball, P.4
Carpenter Jr., W.T.5
-
11
-
-
2642523109
-
Comparison of the effects of quetiapine and haloperidol in a cohort of patients with treatment-resistant schizophrenia
-
Buckley P. Comparison of the effects of quetiapine and haloperidol in a cohort of patients with treatment-resistant schizophrenia. Schizophr. Res. 49(Suppl. 1):2001;221
-
(2001)
Schizophr. Res.
, vol.49
, Issue.SUPPL. 1
, pp. 221
-
-
Buckley, P.1
-
12
-
-
0032966565
-
Clozapine for refractory schizophrenia: The Illinois experience
-
Buckman R.W., Malan R.D. Clozapine for refractory schizophrenia: the Illinois experience. J. Clin. Psychiatry. 60(Suppl. 1):1999;18-22
-
(1999)
J. Clin. Psychiatry
, vol.60
, Issue.SUPPL. 1
, pp. 18-22
-
-
Buckman, R.W.1
Malan, R.D.2
-
13
-
-
0035065899
-
Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: A review and meta-analysis of randomized trials
-
Chakos M., Lieberman J., Hoffman E., Bradford D., Sheitman B. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am. J. Psychiatry. 158(4):2001;518-526
-
(2001)
Am. J. Psychiatry
, vol.158
, Issue.4
, pp. 518-526
-
-
Chakos, M.1
Lieberman, J.2
Hoffman, E.3
Bradford, D.4
Sheitman, B.5
-
14
-
-
0035228691
-
Detecting improvement in quality of life and symptomatology in schizophrenia
-
Cramer J., Rosenheck R., Xu W., Henderson W., Thomas J., Charney D. Detecting improvement in quality of life and symptomatology in schizophrenia. Schizophr. Bull. 27(2):2001;227-234
-
(2001)
Schizophr. Bull.
, vol.27
, Issue.2
, pp. 227-234
-
-
Cramer, J.1
Rosenheck, R.2
Xu, W.3
Henderson, W.4
Thomas, J.5
Charney, D.6
-
15
-
-
0034075361
-
A comparison of the effects of quetiapine ('seroquel') and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment. PRIZE Study Group
-
Emsley R.A., Raniwalla J., Bailey P.J., Jones A.M. A comparison of the effects of quetiapine ('seroquel') and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment. PRIZE Study Group. Int. Clin. Psychopharmacol. 15(3):2000;121-131
-
(2000)
Int. Clin. Psychopharmacol.
, vol.15
, Issue.3
, pp. 121-131
-
-
Emsley, R.A.1
Raniwalla, J.2
Bailey, P.J.3
Jones, A.M.4
-
16
-
-
0029925213
-
Clozapine eligibility among state hospital patients
-
Essock S.M., Hargreaves W.A., Dohm F.A., Goethe J., Carver L., Hipshman L. Clozapine eligibility among state hospital patients. Schizophr. Bull. 22(1):1996;15-25
-
(1996)
Schizophr. Bull.
, vol.22
, Issue.1
, pp. 15-25
-
-
Essock, S.M.1
Hargreaves, W.A.2
Dohm, F.A.3
Goethe, J.4
Carver, L.5
Hipshman, L.6
-
17
-
-
0033396614
-
Treatment-resistant schizophrenia: Reviewing the options and identifying the way forward
-
Hellewell J.S. Treatment-resistant schizophrenia: reviewing the options and identifying the way forward. J. Clin. Psychiatry. 60(Suppl. 23):1999;14-19
-
(1999)
J. Clin. Psychiatry
, vol.60
, Issue.SUPPL. 23
, pp. 14-19
-
-
Hellewell, J.S.1
-
19
-
-
0030825390
-
A double-blind comparative study of clozapine versus chlorpromazine on Chinese patients with treatment-refractory schizophrenia
-
Hong C.J., Chen J.Y., Chiu H.J., Sim C.B. A double-blind comparative study of clozapine versus chlorpromazine on Chinese patients with treatment-refractory schizophrenia. Int. Clin. Psychopharmacol. 12(3):1997;123-130
-
(1997)
Int. Clin. Psychopharmacol.
, vol.12
, Issue.3
, pp. 123-130
-
-
Hong, C.J.1
Chen, J.Y.2
Chiu, H.J.3
Sim, C.B.4
-
20
-
-
0023812652
-
Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine
-
Kane J., Honigfeld G., Singer J., Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch. Gen. Psychiatry. 45(9):1988;789-796
-
(1988)
Arch. Gen. Psychiatry
, vol.45
, Issue.9
, pp. 789-796
-
-
Kane, J.1
Honigfeld, G.2
Singer, J.3
Meltzer, H.4
-
21
-
-
0034799836
-
Clozapine and haloperidol in moderately refractory schizophrenia: A 6-month randomized and double-blind comparison
-
Kane J.M., Marder S.R., Schooler N.R., Wirshing W.C., Umbricht D., Baker R.W., Wirshing D.A., Safferman A., Ganguli R., McMeniman M., Borenstein M. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison. Arch. Gen. Psychiatry. 58(10):2001;965-972
-
(2001)
Arch. Gen. Psychiatry
, vol.58
, Issue.10
, pp. 965-972
-
-
Kane, J.M.1
Marder, S.R.2
Schooler, N.R.3
Wirshing, W.C.4
Umbricht, D.5
Baker, R.W.6
Wirshing, D.A.7
Safferman, A.8
Ganguli, R.9
McMeniman, M.10
Borenstein, M.11
-
22
-
-
0023606101
-
The positive and negative syndrome scale (PANSS) for schizophrenia
-
Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 13(2):1987;261-276
-
(1987)
Schizophr. Bull.
, vol.13
, Issue.2
, pp. 261-276
-
-
Kay, S.R.1
Fiszbein, A.2
Opler, L.A.3
-
23
-
-
10544235439
-
Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison
-
Kumra S., Frazier J.A., Jacobsen L.K., McKenna K., Gordon C.T., Lenane M.C., Hamburger S.D., Smith A.K., Albus K.E., Alaghband-Rad J., Rapoport J.L. Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison. Arch. Gen. Psychiatry. 53(12):1996;1090-1097
-
(1996)
Arch. Gen. Psychiatry
, vol.53
, Issue.12
, pp. 1090-1097
-
-
Kumra, S.1
Frazier, J.A.2
Jacobsen, L.K.3
McKenna, K.4
Gordon, C.T.5
Lenane, M.C.6
Hamburger, S.D.7
Smith, A.K.8
Albus, K.E.9
Alaghband-Rad, J.10
Rapoport, J.L.11
-
24
-
-
0028007550
-
Clinical effects of clozapine in chronic schizophrenia: Response to treatment and predictors of outcome
-
Lieberman J.A., Safferman A.Z., Pollack S., Szymanski S., Johns C., Howard A., Kronig M., Bookstein P., Kane J.M. Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome. Am. J. Psychiatry. 151(12):1994;1744-1752
-
(1994)
Am. J. Psychiatry
, vol.151
, Issue.12
, pp. 1744-1752
-
-
Lieberman, J.A.1
Safferman, A.Z.2
Pollack, S.3
Szymanski, S.4
Johns, C.5
Howard, A.6
Kronig, M.7
Bookstein, P.8
Kane, J.M.9
-
25
-
-
0033804148
-
Treatment refractory schizophrenia
-
Lindenmayer J.P. Treatment refractory schizophrenia. Psychiatr. Q. 71(4):2000;373-384
-
(2000)
Psychiatr. Q.
, vol.71
, Issue.4
, pp. 373-384
-
-
Lindenmayer, J.P.1
-
26
-
-
0028355999
-
Clozapine effects on positive and negative symptoms: A six-month trial in treatment-refractory schizophrenics
-
Lindenmayer J.P., Grochowski S., Mabugat L. Clozapine effects on positive and negative symptoms: a six-month trial in treatment-refractory schizophrenics. J. Clin. Psychopharmacol. 14(3):1994;201-204
-
(1994)
J. Clin. Psychopharmacol.
, vol.14
, Issue.3
, pp. 201-204
-
-
Lindenmayer, J.P.1
Grochowski, S.2
Mabugat, L.3
-
28
-
-
0034924271
-
Olanzapine for schizophrenia refractory to typical and atypical antipsychotics: An open-label, prospective trial
-
Lindenmayer J.P., Volavka J., Lieberman J., Sheitman B., Citrome L., Chakos M., Czobor P., Parker B., Iskander A. Olanzapine for schizophrenia refractory to typical and atypical antipsychotics: an open-label, prospective trial. J. Clin. Psychopharmacol. 21(4):2001;448-453
-
(2001)
J. Clin. Psychopharmacol.
, vol.21
, Issue.4
, pp. 448-453
-
-
Lindenmayer, J.P.1
Volavka, J.2
Lieberman, J.3
Sheitman, B.4
Citrome, L.5
Chakos, M.6
Czobor, P.7
Parker, B.8
Iskander, A.9
-
29
-
-
1842404208
-
Olanzapine in treatment-refractory schizophrenia: Results of an open-label study. The Spanish Group for the Study of Olanzapine in Treatment-Refractory Schizophrenia
-
Martin J., Gomez J.C., Garcia-Bernardo E., Cuesta M., Alvarez E., Gurpegui M. Olanzapine in treatment-refractory schizophrenia: results of an open-label study. The Spanish Group for the Study of Olanzapine in Treatment-Refractory Schizophrenia. J. Clin. Psychiatry. 58(11):1997;479-483
-
(1997)
J. Clin. Psychiatry
, vol.58
, Issue.11
, pp. 479-483
-
-
Martin, J.1
Gomez, J.C.2
Garcia-Bernardo, E.3
Cuesta, M.4
Alvarez, E.5
Gurpegui, M.6
-
30
-
-
0033959580
-
Pharmacogenetics of antipsychotic treatment: Lessons learned from clozapine
-
Masellis M., Basile V.S., Ozdemir V., Meltzer H.Y., Macciardi F.M., Kennedy J.L. Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine. Biol. Psychiatry. 47(3):2000;252-266
-
(2000)
Biol. Psychiatry
, vol.47
, Issue.3
, pp. 252-266
-
-
Masellis, M.1
Basile, V.S.2
Ozdemir, V.3
Meltzer, H.Y.4
MacCiardi, F.M.5
Kennedy, J.L.6
-
31
-
-
0000581521
-
Quetiapine ('Seroquel'); An effective and well-tolerated atypical antipsychotic
-
Meats P. Quetiapine ('Seroquel'); an effective and well-tolerated atypical antipsychotic. Int. J. Psychiatry Clin. Pract. 1:1997;231-239
-
(1997)
Int. J. Psychiatry Clin. Pract.
, vol.1
, pp. 231-239
-
-
Meats, P.1
-
32
-
-
0026796022
-
Treatment of the neuroleptic-nonresponsive schizophrenic patient
-
Meltzer H.Y. Treatment of the neuroleptic-nonresponsive schizophrenic patient. Schizophr. Bull. 18(3):1992;515-542
-
(1992)
Schizophr. Bull.
, vol.18
, Issue.3
, pp. 515-542
-
-
Meltzer, H.Y.1
-
33
-
-
0024443178
-
A prospective study of clozapine in treatment-resistant schizophrenic patients: I. Preliminary report
-
(Suppl.)
-
Meltzer H.Y., Bastani B., Kwon K.Y., Ramirez L.F., Burnett S., Sharpe J. A prospective study of clozapine in treatment-resistant schizophrenic patients: I. Preliminary report. Psychopharmacology (Berl.). 99:1989;S68-S72. (Suppl.)
-
(1989)
Psychopharmacology (Berl.)
, vol.99
-
-
Meltzer, H.Y.1
Bastani, B.2
Kwon, K.Y.3
Ramirez, L.F.4
Burnett, S.5
Sharpe, J.6
-
34
-
-
0024989576
-
Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients
-
Meltzer H.Y., Burnett S., Bastani S., Ramirez L.F. Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hosp. Community Psychiatry. 41(8):1990;892-897
-
(1990)
Hosp. Community Psychiatry
, vol.41
, Issue.8
, pp. 892-897
-
-
Meltzer, H.Y.1
Burnett, S.2
Bastani, S.3
Ramirez, L.F.4
-
35
-
-
0027490173
-
Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia
-
Meltzer H.Y., Cola P., Way L., Thompson P.A., Bastani B., Davies M.A., Snitz B. Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia. Am. J. Psychiatry. 150(11):1993;1630-1638
-
(1993)
Am. J. Psychiatry
, vol.150
, Issue.11
, pp. 1630-1638
-
-
Meltzer, H.Y.1
Cola, P.2
Way, L.3
Thompson, P.A.4
Bastani, B.5
Davies, M.A.6
Snitz, B.7
-
36
-
-
0035688899
-
Pharmacoeconomic evaluation of clozapine in treatment-resistant schizophrenia: A cost-utility analysis
-
Oh P.I., Iskedjian M., Addis A., Lanctot K., Einarson T.R. Pharmacoeconomic evaluation of clozapine in treatment-resistant schizophrenia: a cost-utility analysis. Can. J. Clin. Pharmacol. 8(4):2001;199-206
-
(2001)
Can. J. Clin. Pharmacol.
, vol.8
, Issue.4
, pp. 199-206
-
-
Oh, P.I.1
Iskedjian, M.2
Addis, A.3
Lanctot, K.4
Einarson, T.R.5
-
37
-
-
0003364685
-
Abnormal Involuntary Movement Scale (AIMS)
-
W. Guy. Rockville, MD, USA: National Institute of Mental Health
-
Psychopharmacology Research Branch, NIMH Abnormal Involuntary Movement Scale (AIMS). Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised. DHEW Pub. No. (ADM) 76-338. 1976;534-537 National Institute of Mental Health, Rockville, MD, USA
-
(1976)
ECDEU Assessment Manual for Psychopharmacology, Revised. DHEW Pub. No. (ADM) 76-338
, pp. 534-537
-
-
Research Branch, P.1
Nimh2
-
38
-
-
0033754783
-
The new atypical antipsychotics: A review of pharmacoeconomic studies
-
Revicki D.A. The new atypical antipsychotics: a review of pharmacoeconomic studies. Expert Opin. Pharmacother. 1(2):2000;249-260
-
(2000)
Expert Opin. Pharmacother.
, vol.1
, Issue.2
, pp. 249-260
-
-
Revicki, D.A.1
-
39
-
-
0034041789
-
Long-term efficacy and safety of quetiapine in treatment-refractory schizophrenia: A case report
-
Reznik I., Benatov R., Sirota P. Long-term efficacy and safety of quetiapine in treatment-refractory schizophrenia: a case report. Int. J. Psychiatry Clin. Pract. 4:2000;77-80
-
(2000)
Int. J. Psychiatry Clin. Pract.
, vol.4
, pp. 77-80
-
-
Reznik, I.1
Benatov, R.2
Sirota, P.3
-
40
-
-
0030756517
-
A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia
-
Rosenheck R., Cramer J., Xu W., Thomas J., Henderson W., Frisman L., Fye C., Charney D. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. N. Engl. J. Med. 337(12):1997;809-815
-
(1997)
N. Engl. J. Med.
, vol.337
, Issue.12
, pp. 809-815
-
-
Rosenheck, R.1
Cramer, J.2
Xu, W.3
Thomas, J.4
Henderson, W.5
Frisman, L.6
Fye, C.7
Charney, D.8
-
41
-
-
0033808046
-
Clinical and psychopharmacologic factors influencing family burden in refractory schizophrenia. The Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia
-
Rosenheck R., Cramer J., Jurgis G., Perlick D., Xu W., Thomas J., Henderson W., Charney D. Clinical and psychopharmacologic factors influencing family burden in refractory schizophrenia. The Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. J. Clin. Psychiatry. 61(9):2000;671-676
-
(2000)
J. Clin. Psychiatry
, vol.61
, Issue.9
, pp. 671-676
-
-
Rosenheck, R.1
Cramer, J.2
Jurgis, G.3
Perlick, D.4
Xu, W.5
Thomas, J.6
Henderson, W.7
Charney, D.8
-
43
-
-
0030920294
-
Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group
-
Small J.G., Hirsch S.R., Arvanitis L.A., Miller B.G., Link C.G. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group. Arch. Gen. Psychiatry. 54(6):1997;549-557
-
(1997)
Arch. Gen. Psychiatry
, vol.54
, Issue.6
, pp. 549-557
-
-
Small, J.G.1
Hirsch, S.R.2
Arvanitis, L.A.3
Miller, B.G.4
Link, C.G.5
-
44
-
-
0033815876
-
Risperidone versus clozapine in treatment-resistant schizophrenia: A randomized pilot study
-
Wahlbeck K., Cheine M., Tuisku K., Ahokas A., Joffe G., Rimon R. Risperidone versus clozapine in treatment-resistant schizophrenia: a randomized pilot study. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 24(6):2000;911-922
-
(2000)
Prog. Neuro-Psychopharmacol. Biol. Psychiatry
, vol.24
, Issue.6
, pp. 911-922
-
-
Wahlbeck, K.1
Cheine, M.2
Tuisku, K.3
Ahokas, A.4
Joffe, G.5
Rimon, R.6
-
45
-
-
0032884391
-
Risperidone in treatment-refractory schizophrenia
-
Wirshing D.A., Marshall B.D. Jr., Green M.F., Mintz J., Marder S.R., Wirshing W.C. Risperidone in treatment-refractory schizophrenia. Am. J. Psychiatry. 156(9):1999;1374-1379
-
(1999)
Am. J. Psychiatry
, vol.156
, Issue.9
, pp. 1374-1379
-
-
Wirshing, D.A.1
Marshall Jr., B.D.2
Green, M.F.3
Mintz, J.4
Marder, S.R.5
Wirshing, W.C.6
|